1. Home
  2. THRD vs GHM Comparison

THRD vs GHM Comparison

Compare THRD & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • GHM
  • Stock Information
  • Founded
  • THRD 2019
  • GHM 1936
  • Country
  • THRD United States
  • GHM United States
  • Employees
  • THRD N/A
  • GHM N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • GHM Industrial Machinery/Components
  • Sector
  • THRD Health Care
  • GHM Industrials
  • Exchange
  • THRD Nasdaq
  • GHM Nasdaq
  • Market Cap
  • THRD 513.2M
  • GHM 490.8M
  • IPO Year
  • THRD 2022
  • GHM N/A
  • Fundamental
  • Price
  • THRD $10.84
  • GHM $40.78
  • Analyst Decision
  • THRD Strong Buy
  • GHM Buy
  • Analyst Count
  • THRD 3
  • GHM 1
  • Target Price
  • THRD $20.33
  • GHM $35.00
  • AVG Volume (30 Days)
  • THRD 259.3K
  • GHM 72.3K
  • Earning Date
  • THRD 11-07-2024
  • GHM 02-03-2025
  • Dividend Yield
  • THRD N/A
  • GHM N/A
  • EPS Growth
  • THRD N/A
  • GHM 172.71
  • EPS
  • THRD N/A
  • GHM 0.71
  • Revenue
  • THRD N/A
  • GHM $196,402,000.00
  • Revenue This Year
  • THRD N/A
  • GHM $13.21
  • Revenue Next Year
  • THRD N/A
  • GHM $9.89
  • P/E Ratio
  • THRD N/A
  • GHM $57.22
  • Revenue Growth
  • THRD N/A
  • GHM 11.88
  • 52 Week Low
  • THRD $8.08
  • GHM $18.15
  • 52 Week High
  • THRD $16.94
  • GHM $46.50
  • Technical
  • Relative Strength Index (RSI)
  • THRD 40.49
  • GHM 45.26
  • Support Level
  • THRD $10.53
  • GHM $43.45
  • Resistance Level
  • THRD $11.84
  • GHM $46.50
  • Average True Range (ATR)
  • THRD 0.86
  • GHM 1.93
  • MACD
  • THRD -0.07
  • GHM -0.87
  • Stochastic Oscillator
  • THRD 17.60
  • GHM 17.51

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About GHM Graham Corporation

Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.

Share on Social Networks: